BUSINESS
Lupin soars on getting USFDA’s nod for Liraglutide and Glucagon Injectable Products
Lupin is currently trading at Rs. 1944.70, up by 24.25 points or 1.26% from its previous closing of Rs. 1920.45 on the BSE. The scrip opened at Rs.…
lupin
BUSINESS
Lupin jumps after its arm incorporates wholly owned subsidiary in New Zealand
Lupin is currently trading at Rs. 2062.00, up by 69.30 points or 3.48% from its previous closing of Rs. 1992.70 on the…
BUSINESS
Lupin rises on getting tentative nod for Rivaroxaban Tablets
Lupin is currently trading at Rs. 1455.80, up by 15.50 points or 1.08% from its previous closing of Rs. 1440.30 on the…
INDIA
Lupin shines on getting nod to enter into business transfer agreement with LMSL
Lupin is currently trading at Rs. 1155.00, up by 27.10 points or 2.40% from its previous closing of Rs. 1127.90 on the…
BUSINESS
Lupin rises on getting USFDA’s approval for Obeticholic Acid Tablets
Lupin is currently trading at Rs. 812.90, up by 8.35 points or 1.04% from its previous closing of Rs. 804.55 on the…
BUSINESS
Lupin moves up on launching Regional Reference Laboratory in Indore
Lupin is currently trading at Rs. 756.35, up by 5.10 points or 0.68 % from its previous closing of Rs. 751.25 on…
BUSINESS
Lupin zooms on turning black in Q2FY23
Lupin is currently trading at Rs. 731.85, up by 37.80 points or 5.45% from its previous closing of Rs. 694.05 on the…